Saccharomyces boulardiiSaccharomyces boulardii
probiotic_strain
别名: S. boulardii, CNCM I-745, Florastor, Saccharomyces cerevisiae var. boulardii
About
Saccharomyces boulardii is a non-pathogenic tropical yeast that supports digestive health through multiple mechanisms. Unlike bacterial probiotics, it is naturally resistant to antibiotics, making it uniquely suited for use alongside antibiotic therapy. Research suggests it may help support the body's defense against C. difficile by secreting a protease that degrades toxins A and B, while also enhancing secretory IgA production and stimulating brush border enzyme activity.
How It Works
Non-pathogenic yeast that secretes a 54-kDa protease degrading C. difficile toxins A and B; enhances secretory IgA production protecting mucosal surfaces; stimulates brush border enzymes (lactase, sucrase, maltase); naturally resistant to all antibacterial antibiotics.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| Antibiotic-Associated Diarrhea (AAD) | A | 25 | 5000 | 查看 → |
| Clostridioides difficile Infection (CDI) | B | 6 | 3000 | 查看 → |
| Traveler's Diarrhea | B | 4 | 3200 | 查看 → |
Side Effects
- Mild gas and bloating
- Rare: fungemia in critically ill patients with central venous catheters
- Thirst (yeast may increase water requirements)
- Very rare: potential environmental contamination risk in ICU settings
Drug & Supplement Interactions
- Antifungal medications (may kill S. boulardii, reducing effectiveness)
- Monoamine oxidase inhibitors (S. boulardii contains tyramine)
- Immunosuppressants (theoretical risk of fungemia in immunocompromised patients)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。